Tumour escape from immune surveillance through dendritic cell inactivation.
about
Cathepsin D specifically cleaves the chemokines macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and SLC that are expressed in human breast cancerExercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and ProgressionIn silico proteomic characterization of human epidermal growth factor receptor 2 (HER-2) for the mapping of high affinity antigenic determinants against breast cancerMurine melanoma-infiltrating dendritic cells are defective in antigen presenting function regardless of the presence of CD4CD25 regulatory T cellsAccumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosisRole of STAT3 in cancer metastasis and translational advances.Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses.Nanoparticle-delivered multimeric soluble CD40L DNA combined with Toll-Like Receptor agonists as a treatment for melanoma.Fine-tuning anti-tumor immunotherapies via stochastic simulations.Fluorescent-tilmanocept for tumor margin analysis in the mouse model.Matrix protein mutant of vesicular stomatitis virus stimulates maturation of myeloid dendritic cellsInterleukin-2 inhibits FMS-like tyrosine kinase 3 receptor ligand (flt3L)-dependent development and function of conventional and plasmacytoid dendritic cellsArmed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes.Dendritic cells respond to nasopharygeal carcinoma cells through annexin A2-recognizing DC-SIGN.VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases.Using signaling pathways to overcome immune tolerance to tumors.Impaired CXCL4 expression in tumor-associated macrophages (TAMs) of ovarian cancers arising in endometriosisExosomes and immune surveillance of neoplastic lesions: a review.Tumor cells, rather than dendritic cells, deliver antigen to the lymph node for cross-presentationReversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody.Trial watch: Dendritic cell-based interventions for cancer therapyInduction of potent antitumor immunity by in situ targeting of intratumoral DCs.Tissue-resident dendritic cells and diseases involving dendritic cell malfunctionTumor stress, cell death and the ensuing immune response.TLR signaling by tumor and immune cells: a double-edged sword.Endoscopic ultrasound-guided intratumoural therapy for pancreatic cancer.Signal transducer and activator of transcription-3: a molecular hub for signaling pathways in gliomasInterferon-dependent IL-10 production by Tregs limits tumor Th17 inflammationThe influence of different culture microenvironments on the generation of dendritic cells from non-small-cell lung cancer patients.The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity.The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon.Retrospective chart review of skin cancer presence in the wide excisionsThe evolving role of dendritic cells in cancer therapy.Disarming dendritic cells: a tumor strategy to escape from immune control?Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer.Immunoregulatory actions of polysaccharides from Chinese herbal medicine.The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced toleranceDendritic cell tumor killing activity and its potential applications in cancer immunotherapy.Immature, Semi-Mature, and Fully Mature Dendritic Cells: Toward a DC-Cancer Cells Interface That Augments Anticancer ImmunityEmerging strategies for cancer immunoprevention.
P2860
Q24684115-D1816038-E93B-47B1-895C-F2532ADADF76Q26775189-DC5AFCBF-3849-48E2-A3F7-6B53DECD795AQ28303131-25E7D35B-6FB3-4FF4-9F7F-076ECB340371Q28386617-E706711D-CFB1-40D4-A294-ACEA0DE7A597Q30316394-1FFD0CFE-F052-4263-9B1E-45B07C13A79BQ31142794-162749E9-381C-4950-9388-14E5B2C86C5AQ33203876-5CA5FE66-AE85-456A-9C16-FDE63C26B927Q33509292-6DC8A36F-8712-48D3-81A1-1D56F40401D5Q34248082-411025F3-C0CB-4D87-8A37-BA002CB1FEACQ34363958-71E825DA-B485-4A96-9485-F36815D9C07DQ34434660-E3A77604-8452-4FC4-B57E-4CFE10DA28FBQ34572876-69309F28-A67A-4367-9D89-6C0302CDC430Q35043106-4BE5E2E0-90E9-4D85-A0D1-7D61541B30DDQ35238416-7FD599EC-8A62-4F67-99C3-83A070E5EDD6Q35635564-45BF29CC-8CE5-4919-A704-1EA061659FDEQ35835785-5DB73863-D028-4663-9FDC-FF8A8B6E5FECQ36129961-8CD7DB55-AC17-40CD-95B4-472CC4ECB4D4Q36241867-344759C3-5D17-4926-9D88-7256CEC48110Q36373352-1DF16E3D-76A8-41A7-B48A-B8FEE40934E9Q36376567-198C3E97-56A9-4AA6-9CE7-E408300850A9Q36388529-EE4CF699-A2F8-49C8-B584-0B1C8F56905CQ36441408-E012711D-E42A-415B-BB06-C606BAF64D92Q36759434-026066EA-C3DD-4BB2-80B0-8AFA58524B35Q36997144-A3E578F3-82A3-437C-9C7E-DE38C7B5F555Q37051027-426DDC65-FF07-403C-8AD3-8EA548E22AC3Q37139338-DA3B264D-5CF1-46E9-9C31-278E4DC81F63Q37174303-40F39C9E-EDDB-4479-8468-C298CBB38415Q37259195-F6E3279C-6EF8-4367-AA64-74B75C2260DCQ37397746-D12CAE9C-0E19-4EA1-9D03-78FBF9FD2130Q37541609-910649BB-BA6F-49E1-8FAD-D51787520814Q37561072-8E5CFAFA-F305-4D69-AAD7-33C7D2F8D7A2Q37640178-FE0C6F7F-A4EA-4232-831E-48AE60A76F7FQ37687418-E36B7ED4-B97F-4926-8A1E-94D5FE70E91DQ37755322-E4DAE6BD-0826-4227-8CA6-98585A7F27EFQ37773243-2A037683-72AB-4E84-B819-63E9B2837186Q37807988-E994B46A-0DA2-444E-B199-5568475D535FQ37959968-0F7CC2BA-01CB-4B2D-9298-445D3841C465Q38091116-9916BA19-E683-49F1-A7C2-8A7D9A4B3872Q38174601-72BD27AC-F056-4552-8F5B-DF088719938DQ38585850-96169CC2-D776-4C53-B148-888D19A11EFC
P2860
Tumour escape from immune surveillance through dendritic cell inactivation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Tumour escape from immune surveillance through dendritic cell inactivation.
@ast
Tumour escape from immune surveillance through dendritic cell inactivation.
@en
Tumour escape from immune surveillance through dendritic cell inactivation.
@nl
type
label
Tumour escape from immune surveillance through dendritic cell inactivation.
@ast
Tumour escape from immune surveillance through dendritic cell inactivation.
@en
Tumour escape from immune surveillance through dendritic cell inactivation.
@nl
prefLabel
Tumour escape from immune surveillance through dendritic cell inactivation.
@ast
Tumour escape from immune surveillance through dendritic cell inactivation.
@en
Tumour escape from immune surveillance through dendritic cell inactivation.
@nl
P2093
P356
P1476
Tumour escape from immune surveillance through dendritic cell inactivation.
@en
P2093
Alain P Vicari
Christophe Caux
Giorgio Trinchieri
P356
10.1006/SCBI.2001.0400
P577
2002-02-01T00:00:00Z